You just read:

I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Three Bispecific Antibody Programs

News provided by

I-Mab Biopharma

Sep 26, 2018, 09:23 ET